HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, P Articles by Rosenfeld, R G Search for Related Content PubMed Articles by Cohen, P Articles by Rosenfeld, R G

Prostate specific antigen (PSA) is an insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) protease found in seminal plasma and produced by prostatic epithelial cells (PC-E) in vivo. We examined the effects of PSA-proteolysis of IGFBP-3 on the affinity of IGFBP-3 fragments for IGFs and on the mitogenic action of IGFs on PC-E. Recombinant human IGFBP-3 was cleaved by PSA, then incubated with ¹²⁵I-IGF-I or -II in the presence of varying concentrations of unlabelled peptides, and then cross-linking electrophoresis and densitometric analysis were performed. While the affinity of IGF-II for the PSA-generated IGFBP-3 fragments fell slightly compared to intact IGFBP-3, the affinity of the PSA-generated IGFBP-3 fragments for IGF-I fell by ten fold. The addition of IGF-I or -II to PC-E in serum-free culture conditions resulted in a two-fold stimulation of cell number compared to control. The presence of IGFBP-3 in the media blocked the IGF-induced stimulation, but had no independent effect in the absence of IGFs. When PSA was added to PC-E cultures to which both IGF-I or -II and IGFBP-3 were added, the inhibitory effects of IGFBP-3 on IGF mitogenesis were reversed. We conclude that PSA decreases the affinity of IGFBP-3 for IGF and can potentiate IGF action in the presence of inhibitory IGFBP-3. This phenomenon may contribute to normal and malignant prostate growth.

Journal of Endocrinology (1994) 142, 407–415

This article has been cited by other articles:

				S. D. Cramer, J. Sun, S. L. Zheng, J. Xu, and D. M. Peehl Association of Prostate-Specific Antigen Promoter Genotype with Clinical and Histopathologic Features of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2451 - 2457. [Abstract] [Full Text] [PDF]

				J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis, March 1, 2007; 28(3): 713 - 723. [Abstract] [Full Text] [PDF]

				R. P Singh and R. Agarwal Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer, September 1, 2006; 13(3): 751 - 778. [Abstract] [Full Text] [PDF]

				N. Nadiminty, W. Lou, S. O. Lee, F. Mehraein-Ghomi, J. S. Kirk, J. M. Conroy, H. Zhang, and A. C. Gao Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2 Clin. Cancer Res., March 1, 2006; 12(5): 1420 - 1430. [Abstract] [Full Text] [PDF]

				Y.-S. Zhu, L.-Q. Cai, Y. Huang, J. Fish, L. Wang, Z.-K. Zhang, and J. L. Imperato-McGinley Receptor Isoform and Ligand-Specific Modulation of Dihydrotestosterone-Induced Prostate Specific Antigen Gene Expression and Prostate Tumor Cell Growth by Estrogens J Androl, July 1, 2005; 26(4): 500 - 508. [Abstract] [Full Text] [PDF]

				D. Serrano, L. Baglietto, H. Johansson, F. Mariette, R. Torrisi, M. Onetto, M. Paganuzzi, and A. Decensi Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer Clin. Cancer Res., March 1, 2005; 11(5): 2083 - 2088. [Abstract] [Full Text] [PDF]

				J. T. Arnold, H. Le, K. K. McFann, and M. R. Blackman Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E573 - E584. [Abstract] [Full Text] [PDF]

				J. A. M. J. L. Janssen, M. F. Wildhagen, K. Ito, B. G. Blijenberg, R. H. N. van Schaik, M. J. Roobol, H. A. P. Pols, S. W. J. Lamberts, and F. H. Schroder Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4391 - 4396. [Abstract] [Full Text] [PDF]

				H.-H. Lee, C.-T. Ho, and J.-K. Lin Theaflavin-3,3'-digallate and penta-O-galloyl-{beta}-D-glucose inhibit rat liver microsomal 5{alpha}-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells Carcinogenesis, July 1, 2004; 25(7): 1109 - 1118. [Abstract] [Full Text] [PDF]

				S. D. Cho, C. Jiang, B. Malewicz, Y. Dong, C. Y.F. Young, K.-S. Kang, Y.-S. Lee, C. Ip, and J. Lu Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription Mol. Cancer Ther., May 1, 2004; 3(5): 605 - 612. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]

				S. D. Cramer, B.-L. Chang, A. Rao, G. A. Hawkins, S. L. Zheng, W. N. Wade, R. T. Cooke, L. N. Thomas, E. R. Bleecker, W. J. Catalona, et al. Association Between Genetic Polymorphisms in the Prostate-Specific Antigen Gene Promoter and Serum Prostate-Specific Antigen Levels J Natl Cancer Inst, July 16, 2003; 95(14): 1044 - 1053. [Abstract] [Full Text] [PDF]

				H. T. Le, C. M. Schaldach, G. L. Firestone, and L. F. Bjeldanes Plant-derived 3,3'-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells J. Biol. Chem., May 30, 2003; 278(23): 21136 - 21145. [Abstract] [Full Text] [PDF]

				S. P. Balk, Y.-J. Ko, and G. J. Bubley Biology of Prostate-Specific Antigen J. Clin. Oncol., January 15, 2003; 21(2): 383 - 391. [Abstract] [Full Text] [PDF]

				S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF]

				A. Gsur, M. Preyer, G. Haidinger, T. Zidek, S. Madersbacher, G. Schatzl, M. Marberger, C. Vutuc, and M. Micksche Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk Carcinogenesis, October 1, 2002; 23(10): 1647 - 1651. [Abstract] [Full Text] [PDF]

				R. P. Singh, S. Dhanalakshmi, A. K. Tyagi, D. C. F. Chan, C. Agarwal, and R. Agarwal Dietary Feeding of Silibinin Inhibits Advance Human Prostate Carcinoma Growth in Athymic Nude Mice and Increases Plasma Insulin-like Growth Factor-binding Protein-3 Levels Cancer Res., June 1, 2002; 62(11): 3063 - 3069. [Abstract] [Full Text] [PDF]

				R. Rajah, K.-W. Lee, and P. Cohen Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation Cell Growth Differ., April 1, 2002; 13(4): 163 - 171. [Abstract] [Full Text] [PDF]

				B. A. Booth, M. Boes, B. L. Dake, K. L. Knudtson, and R. S. Bar IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E52 - E58. [Abstract] [Full Text] [PDF]

				P Vilmos, K Gaudenz, Z Hegedus, and J L Marsh The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors Mol. Pathol., October 1, 2001; 54(5): 317 - 323. [Abstract] [Full Text] [PDF]

				S. Melmed CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2929 - 2934. [Full Text] [PDF]

				W.-M. Xue, G. A. Coetzee, R. K. Ross, R. Irvine, L. Kolonel, B. E. Henderson, and S. A. Ingles Genetic Determinants of Serum Prostate-specific Antigen levels in Healthy Men from a Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 575 - 579. [Abstract] [Full Text] [PDF]

				A. P. Chokkalingam, M. Pollak, C.-M. Fillmore, Y.-T. Gao, F. Z. Stanczyk, J. Deng, I. A. Sesterhenn, F. K. Mostofi, T. R. Fears, M. P. Madigan, et al. Insulin-like Growth Factors and Prostate Cancer: A Population-based Case-Control Study in China Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 421 - 427. [Abstract] [Full Text]

				D. E. H. Afar, I. Vivanco, R. S. Hubert, J. Kuo, E. Chen, D. C. Saffran, A. B. Raitano, and A. Jakobovits Catalytic Cleavage of the Androgen-regulated TMPRSS2 Protease Results in Its Secretion by Prostate and Prostate Cancer Epithelia Cancer Res., February 1, 2001; 61(4): 1686 - 1692. [Abstract] [Full Text]

				S. M. Harman, E. J. Metter, M. R. Blackman, P. K. Landis, and H. B. Carter Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4258 - 4265. [Abstract] [Full Text]

				H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF]

				P. Cohen, R. Rajah, J. Rosenbloom, and D. J. Herrick IGFBP-3 mediates TGF-beta 1-induced cell growth in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L545 - L551. [Abstract] [Full Text] [PDF]

				W. Xue, R. A. Irvine, M. C. Yu, R. K. Ross, G. A. Coetzee, and S. A. Ingles Susceptibility to Prostate Cancer: Interaction between Genotypes at the Androgen Receptor and Prostate-specific Antigen Loci Cancer Res., February 1, 2000; 60(4): 839 - 841. [Abstract] [Full Text]

				M. H. Black, M. Giai, R. Ponzone, P. Sismondi, H. Yu, and E. P. Diamandis Serum Total and Free Prostate-specific Antigen for Breast Cancer Diagnosis in Women Clin. Cancer Res., February 1, 2000; 6(2): 467 - 473. [Abstract] [Full Text]

				V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text]

				A. H. Fortier, B. J. Nelson, D. K. Grella, and J. W. Holaday Antiangiogenic Activity of Prostate-Specific Antigen J Natl Cancer Inst, October 6, 1999; 91(19): 1635 - 1640. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				V. C. Russo, G. Rekaris, N. L. Baker, L. A. Bach, and G. A. Werther Basic Fibroblast Growth Factor Induces Proteolysis of Secreted and Cell Membrane-Associated Insulin-Like Growth Factor Binding Protein-2 in Human Neuroblastoma Cells Endocrinology, July 1, 1999; 140(7): 3082 - 3090. [Abstract] [Full Text]

				P. J. Kaplan, S. Mohan, P. Cohen, B. A. Foster, and N. M. Greenberg The Insulin-like Growth Factor Axis and Prostate Cancer: Lessons from the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model Cancer Res., May 1, 1999; 59(9): 2203 - 2209. [Abstract] [Full Text] [PDF]

				R. K. Støving, A. Flyvbjerg, J. Frystyk, S. Fisker, J. Hangaard, M. Hansen-Nord, and C. Hagen Low Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I) in Patients with Anorexia Nervosa Are Not Associated with Increased IGF-Binding Protein-3 Proteolysis J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1346 - 1350. [Abstract] [Full Text]

				R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208. [Abstract] [Full Text]

				V. Hwa, C. Tomasini-Sprenger, A. López Bermejo, R. G. Rosenfeld, and S. R. Plymate Characterization of Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Prostate Cells J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4355 - 4362. [Abstract] [Full Text]

				C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]

				M. J. Horney, D. W. Shirley, D. T. Kurtz, and S. A. Rosenzweig Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1045 - F1053. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				S. Manes, E. Mira, M. d. M. Barbacid, A. Cipres, P. Fernandez-Resa, J. M. Buesa, I. Merida, M. Aracil, G. Marquez, and C. Martinez-A Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3 J. Biol. Chem., October 10, 1997; 272(41): 25706 - 25712. [Abstract] [Full Text] [PDF]

				M. Claussen, B. Kubler, M. Wendland, K. Neifer, B. Schmidt, J. Zapf, and T. Braulke Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D Endocrinology, September 1, 1997; 138(9): 3797 - 3803. [Abstract] [Full Text] [PDF]

				R. Rajah, B. Valentinis, and P. Cohen Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-beta 1 on Programmed Cell Death through a p53- and IGF-independent Mechanism J. Biol. Chem., May 2, 1997; 272(18): 12181 - 12188. [Abstract] [Full Text] [PDF]

				H. Salahifar, R. C. Baxter, and J. L. Martin Insulin-like Growth Factor Binding Protein (IGFBP)-3 Protease Activity Secreted by MCF-7 Breast Cancer Cells: Inhibition by IGFs Does Not Require IGF-IGFBP Interaction Endocrinology, April 1, 1997; 138(4): 1683 - 1690. [Abstract] [Full Text] [PDF]